4L8M
Human p38 MAP kinase in complex with a Dibenzoxepinone
4L8M の概要
| エントリーDOI | 10.2210/pdb4l8m/pdb |
| 関連するPDBエントリー | 3QUD 3QUE |
| 分子名称 | Mitogen-activated protein kinase 14, octyl beta-D-glucopyranoside, N-[2-fluoro-5-({9-[2-(morpholin-4-yl)ethoxy]-11-oxo-6,11-dihydrodibenzo[b,e]oxepin-3-yl}amino)phenyl]benzamide, ... (4 entities in total) |
| 機能のキーワード | protein kinase, selective p38 inhibitor, sar, dibenzoxepinone derivative, dibenzoxepinone, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 42421.40 |
| 構造登録者 | Richters, A.,Mayer-Wrangowski, S.C.,Gruetter, C.,Rauh, D. (登録日: 2013-06-17, 公開日: 2013-10-30, 最終更新日: 2023-09-20) |
| 主引用文献 | Baur, B.,Storch, K.,Martz, K.E.,Goettert, M.I.,Richters, A.,Rauh, D.,Laufer, S.A. Metabolically Stable Dibenzo[b,e]oxepin-11(6H)-ones as Highly Selective p38 MAP Kinase Inhibitors: Optimizing Anti-Cytokine Activity in Human Whole Blood. J.Med.Chem., 56:8561-8578, 2013 Cited by PubMed Abstract: Five series of metabolically stable disubstituted dibenzo[b,e]oxepin-11(6H)-ones were synthesized and tested in a p38α enzyme assay for their inhibition of tumor necrosis factor-α (TNF-α) release in human whole blood. Compared to the monosubstituted dibenzo[b,e]oxepin-11(6H)-one derivatives, it has been shown that the additional introduction of hydrophilic residues at position 9 leads to a substantial improvement of the inhibitory potency and metabolic stability. Using protein X-ray crystallography, the binding mode of the disubstituted dibenzoxepinones and the induction of a glyince flip in the hinge region were confirmed. The most potent compound of this series, 32e, shows an outstanding biological activity on isolated p38α, with an IC50 value of 1.6 nM, extraordinary selectivity (by a factor >1000, Kinase WholePanelProfiler), and low ATP competitiveness. The ability to inhibit the release of TNF-α from human whole blood was optimized down to an IC50 value of 125 nM. With the promising dibenzoxepinone inhibitor 3i, a pharmacokinetic study in mice was conducted. PubMed: 24131218DOI: 10.1021/jm401276h 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.1 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






